Complement Factor B antibody (AA 26-751)
Quick Overview for Complement Factor B antibody (AA 26-751) (ABIN7148380)
Target
See all Complement Factor B (CFB) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 26-751
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Complement factor B protein (26-751AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Complement Factor B (CFB)
-
Alternative Name
- CFB
-
Background
-
Background: Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. It has also been implicated in proliferation and differentiation of preactivated B-lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes.
Aliases: AHUS4 antibody, B factor properdin antibody, BF antibody, BFD antibody, C3 proaccelerator antibody, C3 proactivator antibody, C3/C5 convertase antibody, CFAB antibody, CFAB_HUMAN antibody, CFB antibody, Complement Factor B antibody, Complement factor B Bb fragment antibody, FB antibody, FBI12 antibody, GBG antibody, Glycine rich beta glycoprotein antibody, Glycine-rich beta glycoprotein antibody, H2 Bf antibody, H2BF antibody, PBF2 antibody, Properdin factor B antibody
-
UniProt
- P00751
-
Pathways
- Complement System, Proton Transport, Ribonucleoside Biosynthetic Process
Target
-